Business ❯ Corporate Governance ❯ Shareholder Rights

Securities Regulation

Disclosure Obligations Investor Compensation Class Action Settlements False Statements Investor Protection Class Action Lawsuits Corporate Law Class Action Procedures Market Integrity Market Practices

Atara Investors Urged to Seek Lead Role in Securities Case Ahead of Deadline

Plaintiffs allege undisclosed manufacturing problems alongside ALLELE flaws undermined FDA approval for tabelecleucel.

Eos Energy Investors Face Lead-Plaintiff Deadline in Securities Class Action

Soleno Therapeutics Investors Face May 5 Deadline to Seek Lead Role in Securities Class Action

Law Firms Court Pinterest Investors to Lead Securities Suit Before May 29 Deadline

Rosen Law Firm Urges Hercules Capital Investors to Seek Lead Role Before May 19 Deadline

Alight Investors Pressed to Seek Lead Role in New Securities Class Action by May 15

NuScale Investors Face April 20 Deadline to Lead Securities Class Action

Navan IPO Lawsuit Spurs Investor Push Before April 24 Lead‑Plaintiff Deadline

Plaintiff Firms Step Up uniQure Solicitation After FDA Rebuke, With April 13 Lead-Plaintiff Deadline

Soleno Therapeutics Sued in Federal Securities Class Action Over DCCR Safety Disclosures

Gartner Securities Class Action Spurs Race for Lead Plaintiff Before May 18

Bitdeer Investors Urged to Consider Lead Role in Securities Case as Filing Deadline Approaches

Skye Bioscience Investors Face Jan. 16 Lead-Plaintiff Deadline in Lawsuit Over Nimacimab Claims

DeFi Technologies Faces Securities Class Action in New York as Law Firms Seek Lead Plaintiffs

aTyr Investors Face Dec. 8 Deadline in Securities Suits Over Efzofitimod Trial Failure

Inspire Medical Hit With Securities Class Action Over Inspire V Launch as Firms Court Lead Plaintiffs

Lineage IPO Class Action Nears Sept. 30 Lead‑Plaintiff Deadline as More Firms Court Investors

Lineage Investors Face Sept. 30 Lead‑Plaintiff Deadline as IPO Lawsuit Proceeds in Michigan

Investor Notices Intensify in Lineage IPO Case as Sept. 30 Lead‑Plaintiff Deadline Nears

BlackRock Reduces Stake in Nyxoah Below 3% Threshold